Mackenzie Woodson, MD
Obstetrics & Gynecology · Alabaster, ALNPI 1265938062
Payments from drug & device makers
Across 45 payments — averaging $21.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$276
- Hologic Sales And Service, LLC$77
- Biogen$75
- Pharmacosmos Therapeutics Inc.$66
- AbbVie$58
- Astellas Pharma US Inc$56
- plus $374 from 17 others
What the payments were for
- Food & beverage$982100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 10 | $276 |
| Hologic Sales And Service, LLC | 5 | $77 |
| Biogen | 1 | $75 |
| Pharmacosmos Therapeutics Inc. | 2 | $66 |
| AbbVie | 3 | $58 |
| Astellas Pharma US Inc | 4 | $56 |
| Novo Nordisk | 3 | $52 |
| Sage Therapeutics, LLC | 2 | $33 |
| Baxter Healthcare | 1 | $33 |
| Coopersurgical, Inc. | 1 | $30 |
| Pfizer | 1 | $23 |
| Exact Sciences | 1 | $21 |
| Medtronic | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Monaghan Medical Corporation | 1 | $17 |
| Minerva Surgical, Inc | 1 | $17 |
| Merck | 1 | $16 |
| Bayer | 1 | $16 |
| Axonics, Inc. | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Organon | 1 | $14 |
How this compares
$982 in reported general payments places this provider in the 35th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $607 |
| Fluconazole | 14 | $47 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Alabaster
- Earl SimmonsAlabaster$111K
- James HeadAlabaster$6K
- Guy MiddletonDothan$5.6M
- Charles SharpBirmingham$2.8M
- John WidemanCullman$2.3M
- Charles RogersMobile$1.8M
- Ronald OrsoBirmingham$1.6M
- Amy McCoyMobile$1.2M
- Theodore CatranisMobile$994K
- Theodore TsaltasBirmingham$853K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.